Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback